incadronate has been researched along with Bone Loss, Osteoclastic in 2 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Zoledronic acid (6i) has thus been selected for clinical development under the registered trade name Zometa." | 1.31 | Highly potent geminal bisphosphonates. From pamidronate disodium (Aredia) to zoledronic acid (Zometa). ( Bachmann, R; Bisping, M; Born, AR; Cortesi, R; Glatt, M; Green, JR; Guiglia, G; Jaeggi, KA; Jeker, H; Klein, R; Müller, K; Ramseier, U; Schmid, J; Schreiber, G; Seltenmeyer, Y; Widler, L, 2002) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Szabo, CM | 1 |
| Martin, MB | 1 |
| Oldfield, E | 1 |
| Widler, L | 1 |
| Jaeggi, KA | 1 |
| Glatt, M | 1 |
| Müller, K | 1 |
| Bachmann, R | 1 |
| Bisping, M | 1 |
| Born, AR | 1 |
| Cortesi, R | 1 |
| Guiglia, G | 1 |
| Jeker, H | 1 |
| Klein, R | 1 |
| Ramseier, U | 1 |
| Schmid, J | 1 |
| Schreiber, G | 1 |
| Seltenmeyer, Y | 1 |
| Green, JR | 1 |
2 other studies available for incadronate and Bone Loss, Osteoclastic
| Article | Year |
|---|---|
An investigation of bone resorption and Dictyostelium discoideum growth inhibition by bisphosphonate drugs.
Topics: Alkyl and Aryl Transferases; Animals; Bone Resorption; Crystallography, X-Ray; Dictyostelium; Diphos | 2002 |
Highly potent geminal bisphosphonates. From pamidronate disodium (Aredia) to zoledronic acid (Zometa).
Topics: Animals; Bone Resorption; Calcitriol; Diphosphonates; Hypercalcemia; Imidazoles; In Vitro Techniques | 2002 |